PDT Partners, LLC - TALIS BIOMEDICAL CORP ownership

TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 42 filers reported holding TALIS BIOMEDICAL CORP in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q4 2021$140,000
-25.5%
34,890
+15.9%
0.01%
-21.4%
Q3 2021$188,00030,1090.01%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,095,5340.06%
Baker Brothers Advisors 7,624,835$3,736,1690.02%
PRELUDE CAPITAL MANAGEMENT, LLC 223,934$109,7280.01%
ArrowMark Colorado Holdings LLC 478,862$234,6420.00%
WELLS FARGO & COMPANY/MN 167$820.00%
NORTHERN TRUST CORP 27,860$13,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 144,416$70,7630.00%
STATE STREET CORP 49,536$24,2730.00%
MILLENNIUM MANAGEMENT LLC 163,663$800.00%
View complete list of TALIS BIOMEDICAL CORP shareholders